Sahadain, Julimar S.
HRN: 23-08-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
CEFUROXIME 750MG (VIAL)
05/20/2023
05/27/2023
IV
250mg
Q8
Intraabdominal Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes